Biosurgery | Comprehensive Insights of Recent Developments In Global Industry
The overall biosurgery market is expected to grow from USD 10.67 billion in 2017 and is expected to grow at a CAGR of 6.5% during the forecast period, to reach USD 15.58 billion by 2023.
(firmenpresse) - According to a new market research report "Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023", published by MarketsandMarkets™, the market is expected to reach USD 15.58 billion by 2023 from an estimated USD 11.36 billion in 2018, at a CAGR of 6.5 %.
The key factors that are driving the growth of Biosurgery Market is rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities and growing need for effective blood loss management in patients.
The bone-graft substitutes segment accounted for the largest share of the Biosurgery Market in 2017
On the basis of product, the biosurgery is broadly segmented into bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants & adhesives, adhesion barriers, and staple-line reinforcement agents. In 2017, the bone-graft substitutes segment accounted for the largest share of this market. The large share of this market can be attributed to a large number of commercially available bone grafts and their higher utilization (as compared to other biosurgery products) by surgeons in various surgeries. Advantages such as cost-effectiveness, biocompatible, bioresorbable, osteoconductive, and osteoinductive properties of bone-graft substitutes make them more preferred as compared to other biosurgery products.
Browse and in-depth TOC on "Biosurgery Market"
352 - Tables
56 - Figures
314 - Pages
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302
The reconstructive surgeries segment is expected to register the highest CAGR during the forecast period
Based on applications, the Biosurgery Market is segmented into gynecological surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and thoracic surgeries. The reconstructive surgeries segment is estimated to register the highest CAGR during the forecast period. The growth of this segment is driven by the increasing focus of players on developing surgical sealants for reconstructive surgeries.
North America dominated the market in 2017
North America accounted for the largest share of the Biosurgery Market in 2017, followed by Europe. Increase in the incidence of chronic diseases associated with aging population, increase in the volume of surgical procedures, well-established healthcare services, higher public and private healthcare expenditure, and adoption of highly advanced technology are responsible for the largest share of North America in the Biosurgery Market.
Request Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=166922302
The key players in the global Biosurgery Market are Johnson & Johnson (US), Sanofi (France), Baxter (US), C.R. Bard (US), Integra LifeSciences (US), MAQUET (Sweden), Medtronic (Ireland), Cohera Medical (US), Hemostasis (US), Stryker(US), B.Braun (Germany), CSL (Australia), Pfizer (US), and CryoLife (US).
Weitere Infos zu dieser Pressemeldung:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 09.09.2019 - 11:58 Uhr
Sprache: Deutsch
News-ID 1751452
Anzahl Zeichen: 3636
Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:
Northbrook
Telefon: 18886006441
Kategorie:
Medizintechnik
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 09.09.2019
Diese Pressemitteilung wurde bisher 392 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biosurgery | Comprehensive Insights of Recent Developments In Global Industry"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R
3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private
Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco
Weitere Mitteilungen von MnM
Rhythmus Leben ...
Der Schlaganfall ist weltweit die zweithäufigste Todesursache. Allein in Deutschland erleiden 270.000 Menschen pro Jahr einen Schlaganfall. 75 Prozent, die einen Schlaganfall erleiden, sind älter als 65 Jahre. Zu den Hauptrisiken zählen unentdeckte Herzrhythmusstörungen, vor allem aber Vorhoffli
Profound® - Microneedling reloaded² ...
Das neue Kombinationsverfahren Profound® von Candela verbindet tiefenwirksames Microneedling mit Radiofrequenz; dabei sichert das System erstmalig eine stetige Temperaturkontrolle und gewährleistet damit eine hohe Behandlungssicherheit. ?Profound® ist das einzige temperatur-kontrollierte Micronee
SMTE: GBN Systems beim Innovation Symposium mit einem von 84 Referaten ...
Ein zentraler Aspekt der Swiss Medtech Expo vom 10. bis 11. September 2019 in Luzern ist das Innovation Symposium. Für die diesjährige Fachmesse wurde das Symposium auf zwei Bühnen ausgebaut und befindet sich mitten in der Messehalle. Für René Ziswiler ein richtiger und wichtiger Schritt: «Wir
HELIOS Frankenwaldklinik startet digitale Gesundheitsregion in Oberfranken ...
Die Helios Frankenwaldklinik arbeitet ab dem 01.11.2019 mit der digitalen Plattformlösung ?Pflegeplatzmanager? zur Digitalisierung des Entlass- und Aufnahmemanagements. Die Plattformlösung vernetzt das Krankenhaus mit Pflegeheimen und ambulanten Diensten, um pflegebedürftige Patienten und deren A
